secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0001493152-24-012650
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio issues $6M Series A-1 Preferred to existing investor Patel; convertible into 600K common shares
--------------------------------------------------------------------------------

- Sold 600 shares Series A-1 Preferred Stock at $10,000/share for aggregate $6.0M to The Patel Family, LLP.
- Preferred carries 5% annual cumulative dividend increasing 2% yearly (capped at 15%); convertible into 600,000 common shares.
- Company has call right if 20-day VWAP > $5.00 and resale registration effective; non-voting, no mandatory redemption.
- Investment made under Section 4(a)(2) exemption; existing investor Dr. Manmohan Patel is beneficial owner >5%.
- Series A-1 ranks pari passu with Series A, senior to Common and Series B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224012650/0001493152-24-012650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224012650/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-012650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer